Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

64th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE 2026) 8 - 10 September 2026

Somapacitan in children and adolescents with Noonan syndrome: 2-year REAL8 results including switch from daily GH.

Authors :

Alexander A. L. Jorge¹, Assunta Albanese², Michael Højby³, Thomas Edouard⁴, Anna Grandone⁵, Kamil Soltysik³, Michael Tansey⁶, Hui Yao⁷, Jun Mori⁸

Affiliations

View Details Hide Details

Keywords

Rare Endocrine Disorder

Congress oral presentation

Somapacitan